Good MorningThe rally on Wall Street fizzled on Thursday as investors braced for the September NFP report. The spiking yield on the ten-year treasury has markets nervous the FOMC will hike rates multiple times before it is through, and the NFP report could provide a cause. The ADP report Wednesday was weaker than expected but does not often track in alignment with the NFP: the Challenger, Gray & Christmas report on layoffs and planned hiring shows intent to hire nearly 600,000 seasonal workers this holiday, putting 2023 on track to be the 3rd strongest hiring year on record.
The next test for the market is next week. The PPI and CPI data are due out mid-week and may provide another reason for investors to worry. The latest indications suggest the CPI will accelerate compared to the previous month on a MoM and YoY basis and will lend further evidence that inflation is not tamed.
Also on tap for next week is the start of the Q3 earnings reporting season. The season kicks into high gear on Friday with reports from the major banks. Featured: He started with $2,000. Now he's at $3 million. (Ad) 
|
Technology | |
The list of Most Upgraded Stocks for October, those stocks with the most upgrades in September, is a surprising lot. The list includes five names with one thing in common: AI. The story is the same whether AI-powered security, AI-powered creative services, or AI-powered business efficiency. These ... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Technology | |
The world will never be able to stop the growing demand - and advancements - coming from the chips and semiconductor industry. This is one of those spaces that can be compared to oil booms in decades past, where new companies get involved to increase production and refinery efficiencies and capabi... Read the Full Story |
|
Consumer Discretionary | |
The recent flare up in inflation and interest rates are taking a toll on much of the consumer discretionary sector. Since August 1st, department stores, casinos, RV makers and residential construction companies have been some of the stock market’s worst performers. Even high-flying restauran... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Energy | |
Oil prices corrected in early October, falling 10% from their highs, and Exxon Mobil (NYSE: XOM) with it, but this is not the time to start shedding energy stocks. The price of WTI is up more than 13% from the start of the 3rd quarter and relatively flat compared to the same period last year, sugg... Read the Full Story |
|
Markets | |
In the past week, growth sectors, as tracked by the Technology Select Sector SPDR Fund (NYSEARCA: XLK) and the Communication Services Select Sector SPDR Fund (NYSEARCA: XLC), have been the strongest performers.
As bonds sell-off, investors are shifting their portfolios from dividend stocks to gro... Read the Full Story |
|
From Our Partners | | SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors.
Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now. | | Read Tilson's free analysis and find out what to do with your money |
|
Consumer Discretionary | |
If you were told there was a brand out there that sold 1.9 billion units each day, a brand that is recognized worldwide and accepted by demographics covering all possibilities, a brand whose business generates a steady 10% ROIC (return on invested capital) and above, what type of stock chart comes... Read the Full Story |
|
Industrials | |
Penny stocks can be a treasure trove of investment opportunities, and the list of Most Active Penny Stocks is a good place to start looking. The downside is that many penny stocks are active for no good fundamental reason and have only volatility to offer investors.
Today's list looks at five of... Read the Full Story |
|
Communication Services | |
Though it was looking for a while back in January that last year's slide was being halted, shares of Walt Disney Co (NYSE: DIS) have had a poor 2023. Not only are they now trading below last year's dip and right at the low of 2020's pandemic-inspired selloff, but they're also back trading at 2014 ... Read the Full Story |
|
Markets | |
The risk to the market is mounting, and with it, volatility. The VIX is up nearly 50% in the last month and heading higher, which means the S&P 500 could be heading lower. Based on the outlook for persistent inflation and higher-for-longer interest rates, the S&P 500 could be in for a vola... Read the Full Story |
|
Energy | |
InsiderTrades.com readers know that HighPeak Energy, Inc. (NASDAQ: HPK) insiders are buying in 2023. Purchasing has only been bullish for the last two years and spiked in Q2 following the announcement of a dilutive stock offering and a path to profitability. More than half a dozen execs and major ... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd. | | View Today's Stock Pick |
|
